Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
At the HIV Analyst & Investor Event on Tuesday, Gilead Sciences Inc. (NASDAQ:GILD) revealed that it is developing a ...